FDA panel recommends Sanofi, Isis drug Kynamro for rare disorder

Published October 18, 2012

| Reuters

WASHINGTON – A U.S. Food and Drug Administration panel of outside experts on Thursday recommended Sanofi SA's and Isis Pharmaceutical Inc's drug, Kynamro, for treatment of a rare genetic disorder that causes unusually high cholesterol and life-threatening cardiovascular disease.

(Reporting by David Morgan; Editing by Gerald E. McCormick)

URL

http://www.foxbusiness.com/news/2012/10/18/fda-panel-recommends-sanofi-isis-drug-kynamro-for-rare-disorder/